Topics

Burst Biologics Company Profile

03:44 EST 23rd January 2020 | BioPortfolio

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue processing methodologies, all of which is done at the company’s state-of-the-art research facility. For more information about Burst Biologics or its products, please visit its website at: www.BurstBiologics.com


News Articles [558 Associated News Articles listed on BioPortfolio]

Edwards Warns of Balloon Burst Risk With Sapien 3 Ultra

Reports suggest a low risk of burst balloons during implantation of the TAVR system, but it has prompted a type 1 recall in Canada. News Alerts

Research in Regenerative Medicine proposes a quality control framework for umbilical cord blood-sourced allografts

(Future Science Group) The recent study from Burst Biologics challenges existing standards and outlines future safety and potency benchmarks.

A Fast Radio Burst has Finally Been Traced Back to its Source: the Outskirts of a Galaxy 4 Billion Light-Years Away – Universe Today

A Fast Radio Burst has Finally Been Traced Back to its Source: the Outskirts of a Galaxy 4 Billion Light-Years Away Universe TodayNasa: Source of mysterious alien 'fast radio burst' transmission pinp...

How molecular footballs burst in an X-ray laser beam

An international research team has observed in real time how football molecules made of carbon atoms burst in the beam of an X-ray laser. The study shows the temporal course of the bursting process, ...

Thinner shells for delivering gentler therapeutic bursts

Releasing drugs that are packaged into microcapsules requires a significant amount of force, and the resulting burst can cause damage to human tissues or cause blood clots. A new technique creates lop...

WuXi Biologics Congratulates Tychan on the World's First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers

SHANGHAI, Nov. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discov...

Keeping Track: US FDA Closes Out First Half Of 2019 With CRL For Edsivo, But A Burst Of Supplemental Approvals

The latest drug development news and highlights from our US FDA Performance Tracker.   

Abzena Expands ADC and Biologics Capabilities

Offers integrated clinical translation of biologics with launch ADC Cascade and Biologics Cascade.

PubMed Articles [225 Associated PubMed Articles listed on BioPortfolio]

Balancing benefits and risks in the era of biologics.

Biologics are substances synthetized from biological sources used in the prevention and treatment of several diseases. Rheumatologists have many years of experience with biologics for the treatment of...

Shifting paradigms revisited: biotechnology and the pharmaceutical sciences.

In 2003 Crommelin et al. published an article titled: 'Shifting paradigms: biopharmaceuticals versus low molecular weight drugs' (https://doi.org/10.1016/S0378-5173(03)00376-4). In the current comment...

Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Biologics to clinical practice.

In February 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a novel set of guidelines regarding the use of biologics to manage adult patients with ...

Resurgent Na+ Current Offers Noise Modulation in Bursting Neurons.

Neurons utilize bursts of action potentials as an efficient and reliable way to encode information. It is likely that the intrinsic membrane properties of neurons involved in burst generation may also...

The emergence of new biologics for severe asthma.

Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive treatment with inhaled and oral glucocorticoids. Biologics for severe asthma aim to reduce asthma-re...

Clinical Trials [278 Associated Clinical Trials listed on BioPortfolio]

Burst Biologics Foot and Ankle Registry

This prospective registry was designed as an observational study to ascertain how commercially available Burst Products are being used by foot and ankle surgeons performing procedures whic...

Burst Spinal Cord Stimulation (Burst-SCS) Study

Recently a new form of spinal cord stimulation therapy called burst spinal cord stimulation (Burst-SCS) is available to treat chronic pain. The goal of this study is to learn more about ho...

PET Patterns, Biomarkers and Outcome in Burst SCS Treated FBSS Patients

The primary aim of this study is to investigate cerebral mechanisms of burst stimulation in Failed Back Surgery Syndrome (FBSS) patients treated with Burst Spinal Cord Stimulation (SCS) fo...

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Investigating the Physiology of Targeted Theta-burst Neuromodulation

This research seeks to study the physiological effects of theta-burst transcranial magnetic stimulation (TMS) in the brains of healthy controls using functional MRI and spectroscopy.

Companies [292 Associated Companies listed on BioPortfolio]

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Prellis Biologics, Inc.

Prellis Biologics, Inc. developed the first holographic printing system able to match and accurately replicate human organ and tissue structures for R&D and organ transplan...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

More Information about "Burst Biologics" on BioPortfolio

We have published hundreds of Burst Biologics news stories on BioPortfolio along with dozens of Burst Biologics Clinical Trials and PubMed Articles about Burst Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Burst Biologics Companies in our database. You can also find out about relevant Burst Biologics Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...


Corporate Database Quicklinks



Searches Linking to this Company Record